Clinical trial
Evaluation of the Efficacy and Safety of Cenobamate in Individuals With Autoimmune Epilepsy: a Real-world Study
NCT07474285 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy and Safety of Cenobamate in Individuals With Autoimmune Epilepsy: a Real-world Study
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- February 1, 2026
- Completion date
- August 31, 2027
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune epilepsy